Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Atorvastatin compared with simvastatin in the prevention of CHD morbidity and mortality in patients with CHD

Next Previous
Trial Profile

Atorvastatin compared with simvastatin in the prevention of CHD morbidity and mortality in patients with CHD

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Aug 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atorvastatin (Primary) ; Simvastatin
  • Indications Coronary disorders; Heart failure; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms IDEAL
  • Sponsors Pfizer

    • Most Recent Events

    • 26 Jun 2021 Results of pooled post-hoc analysis of two studies (IDEAL, NCT00159835 and TNT, NCT00327691) were presented at The International Liver Congress 2021.
    • 04 Nov 2016 Results of post-hoc analysis published in the American Journal of Cardiology.
    • 05 Apr 2011 Results of a pharmacogenomic analysis presented in combination with results from the TNT study at the 60th Annual Scientific Session of the American College of Cardiology.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top